We also found that an upregulation of the NK-cell cytotoxicity trigger molecule DNAM-1 on γδ T-cells expanded after exercise and β2-AR agonist infusion, and its ability to ligate with the PVR and Nectin-2 expressed by leukemic targets, were directly involved in the anti-tumor response. The gene discussed is CD226; the disease is neoplasm.